Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Lantheus Medical Imaging
The study will assess the diagnostic efficacy (sensitivity and specificity) of Flurpiridaz F18 Injection MPI against SPECT MPI in patients screened for CAD as determined by ICA. Six hundred and eighty evaluable patients will be enrolled and will undergo SPECT MPI and Flurpiridaz F18 PET MPI. Patients will be considered for enrollment if they are scheduled to undergo or have undergone prior ICA without intervention (being either positive or negative for CAD).
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Invasive Coronary Angiography. Men or Women age 18 or older - see protocol for additional details.
You may not be if
Women who are pregnant, lactating, or of child bearing potential who are not practicing birth control.
Unstable cardiac status. History of coronary artery bypass graft. History of percutaneous coronary intervention within the past six months. See protocol for additional details.
